Growth Metrics

SELLAS Life Sciences Group (SLS) Net Income: 2011-2023

Historic Net Income for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to -$8.2 million.

  • SELLAS Life Sciences Group's Net Income rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 8.31% up from last year.
  • SELLAS Life Sciences Group's Net Income amounted to -$8.2 million in Q4 2023, which was up 12.65% from -$9.4 million recorded in Q3 2023.
  • SELLAS Life Sciences Group's Net Income's 5-year high stood at -$2.2 million during Q1 2021, with a 5-year trough of -$16.7 million in Q1 2022.
  • Its 3-year average for Net Income is -$8.8 million, with a median of -$8.8 million in 2022.
  • As far as peak fluctuations go, SELLAS Life Sciences Group's Net Income surged by 44.76% in 2021, and later crashed by 645.43% in 2022.
  • SELLAS Life Sciences Group's Net Income (Quarterly) stood at -$4.2 million in 2020, then plummeted by 179.37% to -$11.6 million in 2021, then rose by 18.70% to -$9.4 million in 2022, then climbed by 13.43% to -$8.2 million in 2023.
  • Its Net Income was -$8.2 million in Q4 2023, compared to -$9.4 million in Q3 2023 and -$9.1 million in Q2 2023.